Repetitive TMS and Occupational Therapy in Children and Young Adults With Chronic Hemiparesis
- Conditions
- Pediatric StrokeChronic HemiparesisCerebral Palsy
- Interventions
- Device: Repetitive Transcranial Magnetic StimulationDevice: Sham Repetitive Transcranial Magnetic StimulationOther: Occupational Therapy
- Registration Number
- NCT02057276
- Lead Sponsor
- Children's Hospital Medical Center, Cincinnati
- Brief Summary
The purpose of this study is to determine whether Repetitive Transcranial Magnetic Stimulation (rTMS) can augment occupational therapy in improving motor function in children (10 years of age or older) and young adults (\< 21 years of age) with chronic hemiparesis from either stroke or cerebral palsy.
- Detailed Description
RTMS is a noninvasive technology that can induce changes in brain function that may lead to functional improvement in people with hemiparesis. This is a randomized, double-blinded, sham-controlled rTMS study in conjunction with intensive daily occupational therapy (OT) for 2 weeks to improve motor function in hemiparetic patients. Participants will be followed for at least 12 weeks after rTMS to detect any clinical change. The sham group participants will be offered an open-label active rTMS treatment plus OT after the 12 week assessment.
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 2
- Age ≥ 10 years; < 21 years
- Hemiparesis
- Manual Ability Classification System (MACS) level I through IV
- Provision of written informed consent by the patient and/or guardian, including understanding that insurance may be billed for the occupational therapy
- Written assent form signed by participants younger than 18 years of age
- Underlying degenerative or metabolic disorder or supervening medical illness
- Severe depression or other psychiatric disorder
- Any participant who is pregnant
- Any contraindication to TMS (i.e., intracranial metal implants, shunts, ports, pacemaker, baclofen pumps)
- Any changes or addition of neuropsychiatric medications within 1 month of starting the study or during course of the study (if applicable)
- Any botulinum toxin (Botox, Myobloc) or phenol injection within the last 3 months prior to the study or during the course of the study (if applicable)
- Any upper extremity surgery within the last 6 months prior to the study or scheduled during the course of the study (if applicable)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Active rTMS Repetitive Transcranial Magnetic Stimulation Participants will receive daily active rTMS with occupational therapy immediately following rTMS for 10 consecutive weekdays. Active rTMS Occupational Therapy Participants will receive daily active rTMS with occupational therapy immediately following rTMS for 10 consecutive weekdays. Sham rTMS Sham Repetitive Transcranial Magnetic Stimulation Participants will receive daily sham rTMS with occupational therapy immediately following rTMS for 10 consecutive weekdays. Sham rTMS Occupational Therapy Participants will receive daily sham rTMS with occupational therapy immediately following rTMS for 10 consecutive weekdays.
- Primary Outcome Measures
Name Time Method Change in the "Melbourne Assessment of Unilateral Upper Limb Function" Change in the "Melbourne Assessment of Unilateral Upper Limb Function" between baseline and 3 days after rTMS/OT
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Cincinnati Children's Hospital Medical Center
🇺🇸Cincinnati, Ohio, United States